TNNC2 (Gene)

Organism:

Homo sapiens

Synonyms:CFAP85, ENTREZ:7125, FAP85, HGNC:11944, MIM:191039, NM_003279, NP_003270, TNNC2, XM_011529031, XP_011527333, troponin C2, fast skeletal type

Omim:OMIM:191039

Id:ENSG00000101470

Hgnc:HGNC:11944

Entrez:7125

Ensembl:ENSG00000101470

Description:troponin C2, fast skeletal type

Troponin (Tn), a key protein complex in the regulation of striated muscle contraction, is composed of 3 subunits. The Tn-I subunit inhibits actomyosin ATPase, the Tn-T subunit binds tropomyosin and Tn-C, while the Tn-C subunit binds calcium and overcomes the inhibitory action of the troponin complex on actin filaments. The protein encoded by this gene is the Tn-C subunit. [provided by RefSeq, Jul 2008]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View TNNC2's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with TNNC2.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using TNNC2.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for TNNC2.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TNNC2.

Results found

Linked to

	Label	Description
	GSE111247 temozolomide LN-308 2 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE115542 digoxin 5 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE209535 NDRG1 overexpression 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 6 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 10 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 5 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE238213 dopamine 5 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 10 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE164874 prednisolone muscle organ 5 v 9 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE147613 1 V 0 CISPLATIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS

GSE111247 temozolomide LN-308 2 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE115542 digoxin 5 v 4 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE209535 NDRG1 overexpression 1 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 6 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE216043 cisplatin 10 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 5 v 7 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE238213 dopamine 5 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE216043 cisplatin 10 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE164874 prednisolone muscle organ 5 v 9 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE147613 1 V 0 CISPLATIN MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.